These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32588514)

  • 1. Self-managing illicit stimulant use: A qualitative study with patients receiving injectable opioid agonist treatment.
    Palis H; Harrison S; MacDonald S; Marsh DC; Schechter MT; Oviedo-Joekes E
    Drug Alcohol Rev; 2020 Nov; 39(7):914-923. PubMed ID: 32588514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report.
    Palis H; MacDonald S; Jun J; Oviedo-Joekes E
    Harm Reduct J; 2021 May; 18(1):57. PubMed ID: 34016137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment.
    Palis H; Marchand K; Peachey GS; Westfall J; Lock K; MacDonald S; Jun J; Bojanczyk-Shibata A; Harrison S; Marsh DC; Schechter MT; Oviedo-Joekes E
    Subst Abuse Treat Prev Policy; 2021 Sep; 16(1):68. PubMed ID: 34530878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment.
    Marchand K; Foreman J; MacDonald S; Harrison S; Schechter MT; Oviedo-Joekes E
    Subst Abuse Treat Prev Policy; 2020 Jan; 15(1):7. PubMed ID: 31959189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crises.
    Jaffe K; Blawatt S; Lehal E; Lock K; Easterbrook A; MacDonald S; Harrison S; Lajeunesse J; Byres D; Schechter M; Oviedo-Joekes E
    Harm Reduct J; 2023 Apr; 20(1):51. PubMed ID: 37060027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clients' experiences on North America's first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study.
    Oviedo-Joekes E; Dobischok S; Carvajal J; MacDonald S; McDermid C; Klakowicz P; Harrison S; LaJeunesse J; Chow N; Brown M; Gill S; Schechter M
    BMC Health Serv Res; 2023 May; 23(1):553. PubMed ID: 37237256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Patients' Perceptions on Injectable Opioid Agonist Treatment: Influences on Treatment Initiation and Implications for Practice.
    Friedmann Z; Binder A; Kinkel HT; Kühner C; Zsolnai A; Mick I
    Eur Addict Res; 2024; 30(1):32-42. PubMed ID: 38104539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "They Talk to Me Like a Person" Experiences of People in an Injectable Opioid Agonist Treatment Program: A Qualitative Interpretive Description.
    Jackson J; Colborne M; Gadimova F; Kennedy MC
    J Addict Nurs; 2023 Jul-Sep 01; 34(3):166-172. PubMed ID: 37669335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding concurrent stimulant use among people on methadone: A qualitative study.
    McNeil R; Puri N; Boyd J; Mayer S; Hayashi K; Small W
    Drug Alcohol Rev; 2020 Mar; 39(3):209-215. PubMed ID: 32202009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities.
    Friedmann Z; Kinkel HT; Kühner C; Zsolnai A; Mick I; Binder A
    Harm Reduct J; 2023 Nov; 20(1):162. PubMed ID: 37915058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder.
    Wei YJ; Zhu Y; Liu W; Bussing R; Winterstein AG
    JAMA Netw Open; 2018 Aug; 1(4):e181152. PubMed ID: 30646105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Treatment Initiation and Retention Among Individuals Initiated on Injectable Opioid Agonist Therapy for Severe Opioid Use Disorder: A Case Series.
    Giang V; Brar R; Sutherland C; Nolan S
    J Addict Med; 2020; 14(5):437-440. PubMed ID: 32011407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting.
    Dong H; Hayashi K; Milloy MJ; DeBeck K; Singer J; Wong H; Wood E; Kerr T
    Drug Alcohol Depend; 2020 Jul; 212():108005. PubMed ID: 32370932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are prescription misuse and illicit drug use etiologically distinct? A genetically-informed analysis of opioids and stimulants.
    Dash GF; Martin NG; Agrawal A; Lynskey MT; Slutske WS
    Psychol Med; 2022 Oct; 52(14):3176-3183. PubMed ID: 33455586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulant use for self-management of pain among safety-net patients with chronic non-cancer pain.
    Beliveau CM; McMahan VM; Arenander J; Angst MS; Kushel M; Torres A; Santos GM; Coffin PO
    Subst Abus; 2022; 43(1):179-186. PubMed ID: 33798030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant misuse among youth.
    LaBossier NJ; Hadland SE
    Curr Probl Pediatr Adolesc Health Care; 2022 Sep; 52(9):101265. PubMed ID: 36184490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with patient perceived suboptimal dosing of in-hospital opioid agonist therapy among people who use illicit drugs in Vancouver, Canada.
    El-Akkad SE; Nolan S; Hayashi K; Dong H; Milloy MJ; Debeck K; Ti L
    J Addict Dis; 2023; 41(3):204-212. PubMed ID: 35727118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of prospective pharmaceutical stimulant substitution treatments among people who use illicit stimulants in Vancouver, Canada.
    Fleming T; Ivsins A; Barker A; Mansoor M; Mayer S; Vakharia S; McNeil R
    Int J Drug Policy; 2024 Mar; 125():104336. PubMed ID: 38281384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use research.
    Marchand K; Palis H; Guh D; Lock K; MacDonald S; Brissette S; Marsh DC; Harrison S; Schechter MT; Oviedo-Joekes E
    J Subst Abuse Treat; 2022 Jan; 132():108512. PubMed ID: 34098207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness and Attitude Towards Opioid and Stimulant Use and Lifetime Prevalence of the Drugs: A Study in 5 Large Cities of Iran.
    Mohebbi E; Haghdoost AA; Noroozi A; Molavi Vardanjani H; Hajebi A; Nikbakht R; Mehrabi M; Jabbarinejad Kermani A; Salemianpour M; Baneshi MR
    Int J Health Policy Manag; 2019 Apr; 8(4):222-232. PubMed ID: 31050967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.